Citations

Citations to this article as recorded by  

• Non-invasive Risk-based Surveillance Strategy for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
  Ji Won Han
  The Korean Journal of Gastroenterology.2026; 86(1): 62.     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
  Hee Yeon Kim, Miyoung Choi, Dae Won Jun
  Clinical and Molecular Hepatology.2025; 31(1): e48.     CrossRef

Citations

Citations to this article as recorded by  

• Accurate prediction of HCC risk in patients with chronic HBV infection: HBeAg status and HBsAg level matter
  Jimmy Che-To Lai, Anna S.F. Lok
  Hepatology.2026; 83(1): 11.     CrossRef
• Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States
  Kevin Pak, Ryan Sachar, Sammy Saab
  Digestive Diseases and Sciences.2025; 70(4): 1547.     CrossRef
• Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
  Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
• The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
  Wen-Juei Jeng, Grace Lai-Hung Wong
  Hepatology Communications.2023; 7(3): e0060.     CrossRef
• Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
  Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef
• A global investment case for hepatitis B elimination: a modelling study
  Christopher P Seaman, Phillip Luong, Yinzong Xiao, Romesh Abeysuriya, Jess Howell, Margaret Hellard, Nick Scott
  The Lancet Gastroenterology & Hepatology.2023; 8(10): 932.     CrossRef
• Correlation between contrast-enhanced ultrasound perfusion parameters and EphB4 expression in hepatocellular carcinoma lesions
  Chen-ZhuoYa Sheng, Gen-Xin Yao, Xin-Rong Zhang, Dong Li
  World Chinese Journal of Digestology.2021; 29(18): 1084.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef